← Leaderboards
Richard M Wright
University Of Colorado Denver
$364,529
Attributed
$575,058
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $231.4K · FY2005–14$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$575,058 · 2
By mechanism
R21$421,058 · 1
R03$154,000 · 1
Top collaborators
- Richard Joseph Johnson2 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Isabel Rubio Schlaepfer$614,790
- Miguel Angel Lanaspa Garcia$4,460,819
- Angelo D'alessandro$12,761,823
- Kirk C Hansen$5,495,211
- Heide L Ford$14,422,349
Others in their field
Top investigators on “Drug Design /Synthesis /Production”
- Dennis L. Kasper · Harvard Medical School$26,605,444
- Myron Max Levine · University Of Maryland Baltimore$22,074,862
- George R Painter · Chimerix, Inc.$19,230,662
- Donald L Fine · Dynport Vaccine Company, Llc$9,996,228
- Dennis E. Hruby · Oregon State University$9,654,233
- William C Olson · Progenics Pharmaceuticals, Inc.$8,361,679
Research focus
Drug Design /Synthesis /ProductionNeoplasm /Cancer Nutrition TherapyLaboratory MouseAdhesionsAdult Respiratory Distress SyndromeAffectAdiponectinApplications GrantsBenzopyrenesCancer PreventionCarbon DioxideCardiovascular DiseasesCcl2 GeneChemopreventionChronic Obstructive Airway DiseaseChronicClinical TrialsColoradoComorbidityComplexCytokineAnimal ModelEnrollmentAdipocytes
Grant awards (4)
PROINFLAMMATORY ROLE OF URIC ACID IN LUNG DISEASE: NOVEL MODELS AND CLINICAL VALI$189,620
R21 · FY2014 · HL · contact PI
PROINFLAMMATORY ROLE OF URIC ACID IN LUNG DISEASE: NOVEL MODELS AND CLINICAL VALI$231,438
R21 · FY2013 · HL · contact PI
Lung cancer chemoprevention and tocopheryl succinate$77,000
R03 · FY2005 · CA
Lung cancer chemoprevention and tocopheryl succinate$77,000
R03 · FY2004 · CA